Xi'an TianLong Science and Technology Co., Ltd.

Main products: Nucleic Acid Purification/Extraction System, PCR, Thermostat, Multi-Parameter Water Quality Analyzer

Gold Member Business License 29 Years in Business
Xi'an TianLong Science and Technology Co., Ltd. booth banner
Xi'an TianLong Science and Technology Co., Ltd. factory and office building

Company Overview

Xi'an TianLong Science and Technology Co., Ltd.

Xi'an Tianlong Technology Co., Ltd. (hereinafter referred to as Tianlong Technology) was established in 1997. It is a high-tech enterprise with the market as the guide, industry, academia and research as the foundation, innovation-driven as the core, and a high degree of brand independence. After more than 20 years, Tianlong Technology has gradually developed into a cross-regional enterprise cluster composed of Xi'an Tianlong, Suzhou Tianlong, Wuxi Ruiqi and other companies. The company adheres to the development philosophy of serving the public with science and technology and being customer-centered, and has always been committed to the research and development, production and overall solution provision of instruments and in vitro diagnostic reagents in the fields of genetic testing and molecular diagnosis. Tianlong Technology has led and participated in hundreds of national, provincial and municipal key scientific research projects, including national key research and development plans, national major scientific instrument and equipment development projects, major national infectious disease prevention and control projects, national 863 plans, national science and technology support plans, etc., and related products have achieved strategic transformation. The "Key Technologies and Industrial Applications of High-Throughput Multi-target Nucleic Acid Automated Quantitative Detection" project jointly applied by the company and Xi'an Jiaotong University won the "Second Prize of the National Science and Technology Progress Award in 2020". The founder team, Professor Peng Niancai, General Manager Dr. Li Ming, and Chief Technology Officer Dr. Miao Baogang were the top three achievers of this award. In addition, the company has also won many honors and qualifications such as the National Specialized and New "Little Giant" Enterprise, the National High-tech Enterprise, the National Intellectual Property Demonstration Enterprise, and the National Development and Reform Commission Biomedical Engineering High-tech Industrialization Demonstration Enterprise. Tianlong Technology always adheres to independent research and development and innovation. In 2002, it obtained the qualification of a domestic Class III medical device manufacturer. In the same year, it developed the first PCR instrument, and obtained the national medical device registration certificate the following year. The subsequent fluorescence quantitative PCR instrument also passed the provincial and ministerial level scientific and technological achievements appraisal in 2006. The company has now passed ISO9001, 13485 quality system certification and veterinary drug GMP workshop certification, and has established more than 10,000 square meters of GMP-compliant production bases in Xi'an, Suzhou and Wuxi, including standardized production workshops, quality inspection laboratories, environmental laboratories, etc. The company has long been deeply involved in the fields of genetic testing and molecular diagnosis, and took the lead in formulating industry standards "Nucleic Acid Extraction Kit (Magnetic Bead Method) (YY/T1717-2020)", "Nucleic Acid Extraction Instrument (YY/T1908-2023)", and the national standard "General Principles for Performance Evaluation of Real-Time Fluorescent Quantitative PCR Instruments (GB/T 42753-2023)", leading the development of industry standards. Up to now, the company has more than 150 independent intellectual property rights such as invention patents, utility models, and software copyrights. The products cover everything from nano-magnetic bead nucleic acid extractors, gene amplification thermal cyclers, real-time fluorescence quantitative PCR machines, nucleic acid detection all-in-one machines, fully automatic sample processing systems and other genetic testing related instruments and equipment to large-scale automated nucleic acid workstations and nucleic acid testing assembly lines. There are hundreds of supporting reagents, covering many fields such as clinical diagnosis and treatment, public health, food safety, forensic identification, scientific research and so on. Up to now, the products have obtained more than 80 domestic medical device registrations and filings (NMPA), and more than 240 international certifications and registrations such as EU CE, US FDA, and Korean KFDA. More than 30 products, including viral hepatitis, respiratory diseases, hand, foot and mouth disease, genetic diseases, personalized medicine, tumor diagnosis and treatment, eugenics and eugenics, etc., have passed the national Class III medical device registration and approval, and have been industrialized. Tianlong reagents have high sensitivity, good specificity, accurate quantification, reliable results, and convenient operation. They have been proven in practice by tens of thousands of units at home and abroad. Domestically, the company's products are widely used in thousands of medical institutions, centers for disease control and prevention, and third-party medical laboratories in more than 30 provinces, autonomous regions, and municipalities. According to multiple third-party authoritative statistics, Tianlong's nucleic acid extraction and fluorescent PCR products have broken the import monopoly and have long been at the forefront of domestic market sales. The user coverage of Tianlong in the top 100 and top 10 hospitals in the country exceeds 90%, and the national, provincial and municipal CDCs are close to full coverage. The product share in 100 national public testing laboratories reaches 99%. Throughout the world, the company's products have been used in more than 100 countries and regions including the United States, Germany, France, Italy, Japan, South Korea, Singapore, the United Arab Emirates, and Indonesia. Tianlong Technology has always been responsible for meeting the major needs of the country and society. It has successively assisted in the prevention and control of public health events such as SARS, H1N1, avian influenza H7N9, Ebola, MERS, yellow fever, Zika, African swine fever, COVID-19, monkeypox, etc. It has provided overall molecular diagnostic solutions as soon as possible, and won the honorary title of "Advanced Collective in Fighting the New Coronavirus Epidemic" by the National Science and Technology and Industry Information System.The company also actively participates in major domestic and foreign events and event guarantees such as the National "Two Sessions", National Games, China International Import Expo, Central Asia Summit, G20 Summit, and Tokyo Olympics, using hard-core technology to "protect" various activities. In the future, Tianlong Technology will always be guided by national and social needs, take establishing a national brand as its own responsibility, continuously promote product iteration with scientific and technological innovation, promote high-quality development of new productive forces, and strive to contribute China's strength to building a human health community.

ManufacturerBusiness Type
1997Year Established
-Overseas Office
Private CompanyCompany Type

Contact Us

Lu Yong

Xi'an TianLong Science and Technology Co., Ltd.

Tianlong Science and Technology Industrial Park, No. 4266, Shanglin Road, High-speed Railway New Town, Xi'an Economic and Technological Development Zone, Shaanxi Province

Send your message to this supplier

Get quotes from multiple Verified Suppliers simultaneously.